AI-assisted health education for people with blood cancers
The Impact of Artificial Intelligence-Assisted Health Education on Patients' Intention to Participate in Clinical Trials: A Cluster-Randomised Controlled Trial
This project tests whether an AI chatbot can improve awareness of clinical trials and willingness to join among adults with blood cancers.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 196 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Zhongnan Hospital Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Trial ID | NCT07305337 on ClinicalTrials.gov |
What this trial studies
Adults with hematologic malignancies who meet eligibility are randomly assigned to receive an AI-robot–delivered health education intervention or usual information. The intervention delivers standardized clinical trial information via an AI bot and measures changes in patients' knowledge, attitudes, and intention to participate. Outcomes are collected using questionnaires and intention measures before and after the intervention to compare groups. The study also examines feasibility and potential for scaling this AI-assisted education approach in routine care.
Who should consider this trial
Good fit: Adults (age ≥18) diagnosed with a hematologic malignancy who are conscious, able to understand and communicate, and willing to give informed consent are the ideal candidates.
Not a fit: Patients with significant cognitive impairment, severe psychiatric disorders, very short expected hospital stays, those receiving end-of-life palliative care, or those who have already completed other clinical trial education programs are unlikely to benefit.
Why it matters
Potential benefit: If successful, the AI education approach could increase patient understanding of clinical trials and help more eligible patients consider joining them.
How similar studies have performed: Some digital and AI-driven education programs have improved patient knowledge and engagement, but AI-robot–delivered clinical trial education specific to blood cancers is relatively new with limited direct evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria (1) Aged ≥18 years with clear consciousness; (2) Diagnosed with haematological malignancy meeting clinical treatment criteria (WHO criteria); (3) Capable of understanding health education content and possessing basic communication skills; (4) Willing to participate in this study and sign an informed consent form. Exclusion Criteria (1) Patients with concomitant cognitive impairment, psychiatric disorders, or other conditions severely affecting comprehension; (2) Anticipated hospital stay of less than 3 days, rendering completion of the intervention unfeasible; (3) End-of-life palliative care; (4) Previous participation in other clinical trial education programmes.
Where this trial is running
Wuhan, Hubei
- Zhongnan Hospital of Wuhan University — Wuhan, Hubei, China (Recruiting)
Study contacts
- Study coordinator: Fuling Zhou
- Email: zhoufuling@163.com.cn
- Phone: 027-67813137
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.